Hims Days Sales Outstanding vs Price To Sales Ratio Analysis

HIMS Stock

USD 39.49 2.42 6.53%

Hims Hers financial indicator trend analysis is much more than just examining Hims Hers Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hims Hers Health is a good investment. Please check the relationship between Hims Hers Days Sales Outstanding and its Price To Sales Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hims Hers Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

Days Sales Outstanding vs Price To Sales Ratio

Days Sales Outstanding vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hims Hers Health Days Sales Outstanding account and Price To Sales Ratio. At this time, the significance of the direction appears to have strong relationship.

The correlation between Hims Hers' Days Sales Outstanding and Price To Sales Ratio is 0.63. Overlapping area represents the amount of variation of Days Sales Outstanding that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Hims Hers Health, assuming nothing else is changed. The correlation between historical values of Hims Hers' Days Sales Outstanding and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Days Sales Outstanding of Hims Hers Health are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Days Sales Outstanding i.e., Hims Hers' Days Sales Outstanding and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

0.63

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Days Sales Outstanding

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Hims Hers Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Hims Hers sales, a figure that is much harder to manipulate than other Hims Hers Health multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Hims Hers' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hims Hers Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hims Hers Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

At this time, Hims Hers' Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 66.62 in 2025, despite the fact that Tax Provision is likely to grow to (51.6 M).

	2022	2023	2024	2025 (projected)
Gross Profit	408.7M	714.9M	1.2B	1.2B
Total Revenue	526.9M	872M	1.5B	1.6B

Gross Profit Total Revenue

Hims Hers fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue
Total Assets		0.18	0.84	0.94	0.93	0.92	-0.92	-0.8	0.93	0.91	1.0	0.11	0.19	0.91	0.87	0.87	-0.12	0.94	0.95	0.88	0.51	0.92	-0.77	-0.61	0.92	0.85
Short Long Term Debt Total	0.18		0.13	0.32	0.35	0.22	-0.39	0.12	0.37	0.4	0.22	0.24	-0.38	0.12	0.27	0.28	-0.66	0.29	0.19	0.14	-0.32	0.17	0.36	0.15	0.36	0.33
Other Current Liab	0.84	0.13		0.74	0.8	0.84	-0.73	-0.73	0.66	0.69	0.82	0.16	0.55	0.94	0.86	0.84	-0.1	0.69	0.69	0.86	0.47	0.93	-0.77	-0.5	0.67	0.59
Total Current Liabilities	0.94	0.32	0.74		0.87	0.79	-0.99	-0.56	0.98	0.99	0.95	0.17	0.02	0.77	0.74	0.72	-0.18	0.99	0.93	0.7	0.48	0.8	-0.58	-0.47	0.98	0.97
Total Stockholder Equity	0.93	0.35	0.8	0.87		0.98	-0.84	-0.75	0.87	0.84	0.95	0.36	0.21	0.86	0.85	0.93	-0.45	0.86	0.82	0.9	0.18	0.86	-0.62	-0.39	0.84	0.74
Net Tangible Assets	0.92	0.22	0.84	0.79	0.98		-0.75	-0.84	0.78	0.74	0.92	0.32	0.34	0.9	0.88	0.96	-0.38	0.78	0.78	0.95	0.2	0.89	-0.71	-0.44	0.75	0.63
Net Debt	-0.92	-0.39	-0.73	-0.99	-0.84	-0.75		0.51	-0.98	-1.0	-0.93	-0.15	0.03	-0.75	-0.73	-0.7	0.19	-0.98	-0.92	-0.67	-0.48	-0.78	0.53	0.46	-0.98	-0.98
Retained Earnings	-0.8	0.12	-0.73	-0.56	-0.75	-0.84	0.51		-0.57	-0.49	-0.77	0.01	-0.33	-0.88	-0.88	-0.86	-0.06	-0.59	-0.73	-0.93	-0.45	-0.85	0.91	0.64	-0.58	-0.38
Accounts Payable	0.93	0.37	0.66	0.98	0.87	0.78	-0.98	-0.57		0.99	0.95	0.17	-0.12	0.74	0.74	0.73	-0.22	0.99	0.95	0.7	0.44	0.77	-0.55	-0.45	0.99	0.96
Cash	0.91	0.4	0.69	0.99	0.84	0.74	-1.0	-0.49	0.99		0.93	0.17	-0.06	0.72	0.7	0.68	-0.22	0.98	0.91	0.64	0.44	0.75	-0.5	-0.43	0.98	0.98
Non Current Assets Total	1.0	0.22	0.82	0.95	0.95	0.92	-0.93	-0.77	0.95	0.93		0.16	0.14	0.89	0.86	0.87	-0.18	0.96	0.95	0.87	0.47	0.91	-0.74	-0.56	0.94	0.87
Non Currrent Assets Other	0.11	0.24	0.16	0.17	0.36	0.32	-0.15	0.01	0.17	0.17	0.16		0.02	0.03	0.15	0.28	-0.78	0.14	-0.05	0.18	-0.57	0.04	0.06	0.69	0.12	0.1
Other Assets	0.19	-0.38	0.55	0.02	0.21	0.34	0.03	-0.33	-0.12	-0.06	0.14	0.02		0.41	0.18	0.28	0.04	-0.06	-0.07	0.34	0.08	0.33	-0.39	-0.28	-0.15	-0.14
Cash And Short Term Investments	0.91	0.12	0.94	0.77	0.86	0.9	-0.75	-0.88	0.74	0.72	0.89	0.03	0.41		0.93	0.93	-0.04	0.76	0.82	0.96	0.53	0.99	-0.84	-0.64	0.74	0.63
Net Receivables	0.87	0.27	0.86	0.74	0.85	0.88	-0.73	-0.88	0.74	0.7	0.86	0.15	0.18	0.93		0.93	-0.14	0.73	0.81	0.95	0.43	0.94	-0.79	-0.5	0.77	0.58
Common Stock Shares Outstanding	0.87	0.28	0.84	0.72	0.93	0.96	-0.7	-0.86	0.73	0.68	0.87	0.28	0.28	0.93	0.93		-0.35	0.73	0.75	0.98	0.23	0.93	-0.72	-0.42	0.71	0.55
Non Current Liabilities Total	-0.12	-0.66	-0.1	-0.18	-0.45	-0.38	0.19	-0.06	-0.22	-0.22	-0.18	-0.78	0.04	-0.04	-0.14	-0.35		-0.15	0.03	-0.19	0.75	-0.05	-0.32	-0.51	-0.14	-0.11
Inventory	0.94	0.29	0.69	0.99	0.86	0.78	-0.98	-0.59	0.99	0.98	0.96	0.14	-0.06	0.76	0.73	0.73	-0.15		0.96	0.71	0.5	0.8	-0.6	-0.49	0.98	0.97
Other Current Assets	0.95	0.19	0.69	0.93	0.82	0.78	-0.92	-0.73	0.95	0.91	0.95	-0.05	-0.07	0.82	0.81	0.75	0.03	0.96		0.77	0.63	0.84	-0.72	-0.65	0.96	0.89
Other Stockholder Equity	0.88	0.14	0.86	0.7	0.9	0.95	-0.67	-0.93	0.7	0.64	0.87	0.18	0.34	0.96	0.95	0.98	-0.19	0.71	0.77		0.35	0.95	-0.82	-0.52	0.69	0.52
Total Liab	0.51	-0.32	0.47	0.48	0.18	0.2	-0.48	-0.45	0.44	0.44	0.47	-0.57	0.08	0.53	0.43	0.23	0.75	0.5	0.63	0.35		0.55	-0.69	-0.75	0.51	0.51
Total Current Assets	0.92	0.17	0.93	0.8	0.86	0.89	-0.78	-0.85	0.77	0.75	0.91	0.04	0.33	0.99	0.94	0.93	-0.05	0.8	0.84	0.95	0.55		-0.83	-0.62	0.78	0.67
Short Term Debt	-0.77	0.36	-0.77	-0.58	-0.62	-0.71	0.53	0.91	-0.55	-0.5	-0.74	0.06	-0.39	-0.84	-0.79	-0.72	-0.32	-0.6	-0.72	-0.82	-0.69	-0.83		0.64	-0.58	-0.45
Other Liab	-0.61	0.15	-0.5	-0.47	-0.39	-0.44	0.46	0.64	-0.45	-0.43	-0.56	0.69	-0.28	-0.64	-0.5	-0.42	-0.51	-0.49	-0.65	-0.52	-0.75	-0.62	0.64		-0.48	-0.43
Property Plant And Equipment Net	0.92	0.36	0.67	0.98	0.84	0.75	-0.98	-0.58	0.99	0.98	0.94	0.12	-0.15	0.74	0.77	0.71	-0.14	0.98	0.96	0.69	0.51	0.78	-0.58	-0.48		0.96
Current Deferred Revenue	0.85	0.33	0.59	0.97	0.74	0.63	-0.98	-0.38	0.96	0.98	0.87	0.1	-0.14	0.63	0.58	0.55	-0.11	0.97	0.89	0.52	0.51	0.67	-0.45	-0.43	0.96

Click cells to compare fundamentals

Hims Hers Account Relationship Matchups

Hims Hers fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	118.7M	420.6M	366.3M	441.2M	707.5M	742.9M
Other Current Liab	5.2M	54.1M	11.5M	34.4M	53.0M	27.0M
Total Current Liabilities	15.2M	79.2M	47.9M	88.5M	221.4M	232.4M
Total Stockholder Equity	(146.9M)	334.6M	311.7M	344.0M	476.7M	500.6M
Net Tangible Assets	(141.1M)	(149.8M)	197.8M	170.8M	196.4M	206.3M
Net Debt	(27.3M)	(66.3M)	(41.5M)	(86.7M)	(209.2M)	(198.8M)
Retained Earnings	(171.3M)	(279.0M)	(344.6M)	(368.2M)	(242.1M)	(254.2M)
Accounts Payable	8.1M	19.6M	32.4M	43.1M	91.2M	95.7M
Cash	27.3M	71.8M	46.8M	96.7M	220.6M	231.6M
Non Current Assets Total	5.6M	150.7M	149.7M	176.1M	311.7M	327.3M
Non Currrent Assets Other	(199.0M)	8.8M	889K	947K	1.0M	1.1M
Other Assets	1.0M	8.8M	888K	1.0	1.15	1.09
Cash And Short Term Investments	100.2M	247.3M	179.6M	221.0M	300.3M	180.7M
Net Receivables	750K	3.6M	3.2M	6.7M	6.1M	3.4M
Common Stock Shares Outstanding	35.4M	186.8M	204.5M	209.3M	236.8M	153.2M
Liabilities And Stockholders Equity	118.7M	420.6M	366.3M	441.2M	707.5M	742.9M
Non Current Liabilities Total	250.3M	6.7M	6.7M	8.7M	9.5M	9.0M
Inventory	3.5M	13.6M	21.6M	22.5M	64.4M	67.6M
Other Current Assets	8.6M	5.5M	12.2M	14.9M	25.1M	26.3M
Other Stockholder Equity	24.4M	613.7M	656.6M	712.3M	719.2M	432.0M
Total Liab	265.6M	86.0M	54.6M	97.2M	230.8M	151.8M
Total Current Assets	113.1M	269.9M	216.6M	265.1M	395.8M	216.5M
Accumulated Other Comprehensive Income	(11K)	(137K)	(277K)	(124K)	(324K)	(307.8K)
Short Term Debt	4.3M	1.4M	1.7M	1.3M	1.9M	2.3M
Property Plant And Equipment Net	1.7M	5.1M	16.1M	45.7M	93.0M	97.6M
Current Deferred Revenue	1.3M	3.2M	1.5M	7.7M	75.3M	79.0M
Short Term Investments	72.9M	175.5M	132.9M	124.3M	79.7M	114.2M
Net Invested Capital	193.5M	334.6M	311.7M	344.0M	476.7M	340.5M
Net Working Capital	(3.8M)	190.7M	168.7M	176.6M	174.5M	129.7M
Intangible Assets	59K	25.9M	21.8M	18.6M	43.4M	45.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Hims Stock Analysis

When running Hims Hers' price analysis, check to measure Hims Hers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hims Hers is operating at the current time. Most of Hims Hers' value examination focuses on studying past and present price action to predict the probability of Hims Hers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hims Hers' price. Additionally, you may evaluate how the addition of Hims Hers to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC